
### [NCIT:C4665](http://purl.obolibrary.org/obo/NCIT_C4665)
**Label:** Plasma Cell Neoplasm

**Subclasses:** [NCIT:C7813](http://purl.obolibrary.org/obo/NCIT_C7813) (Refractory Plasma Cell Neoplasm), [NCIT:C4734](http://purl.obolibrary.org/obo/NCIT_C4734) (Non-Secretory Plasma Cell Myeloma), [NCIT:C7765](http://purl.obolibrary.org/obo/NCIT_C7765) (Osteosclerotic Plasma Cell Myeloma), [NCIT:C7149](http://purl.obolibrary.org/obo/NCIT_C7149) (Smoldering Plasma Cell Myeloma), [NCIT:C7812](http://purl.obolibrary.org/obo/NCIT_C7812) (Solitary Osseous Plasmacytoma), [NCIT:C9349](http://purl.obolibrary.org/obo/NCIT_C9349) (Plasmacytoma), [NCIT:C6932](http://purl.obolibrary.org/obo/NCIT_C6932) (Solitary Plasmacytoma), [NCIT:C4002](http://purl.obolibrary.org/obo/NCIT_C4002) (Extraosseous Plasmacytoma), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C3242](http://purl.obolibrary.org/obo/NCIT_C3242) (Plasma Cell Myeloma), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C3180](http://purl.obolibrary.org/obo/NCIT_C3180) (Plasma Cell Leukemia), [NCIT:C118421](http://purl.obolibrary.org/obo/NCIT_C118421) (Anaplastic Plasmacytoma), 

**Class expressions from DL-Learner:**

- Thing 51.30%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37183](http://purl.obolibrary.org/obo/NCIT_C37183) (Neoplastic B-Prolymphocyte))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37181](http://purl.obolibrary.org/obo/NCIT_C37181) (Neoplastic Monoblast))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37180](http://purl.obolibrary.org/obo/NCIT_C37180) (Medium-Sized Neoplastic Myeloblast with Coarse Cytoplasmic Basophilic Granules))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C3718](http://purl.obolibrary.org/obo/NCIT_C3718) (Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37179](http://purl.obolibrary.org/obo/NCIT_C37179) (Neoplastic Myeloblast without Azurophilic Granules))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37178](http://purl.obolibrary.org/obo/NCIT_C37178) (Neoplastic Myeloblast with Azurophilic Granules))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37177](http://purl.obolibrary.org/obo/NCIT_C37177) (Neoplastic Medium-Sized Myeloblast with Basophilic Agranular Cytoplasm))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37176](http://purl.obolibrary.org/obo/NCIT_C37176) (Neoplastic Myeloblast with Abundant Basophilic Cytoplasm))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37175](http://purl.obolibrary.org/obo/NCIT_C37175) (Neutrophil with Pseudo Chediak-Higashi Granules))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37174](http://purl.obolibrary.org/obo/NCIT_C37174) (Neutrophil with Cytoplasmic Hypogranularity))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37172](http://purl.obolibrary.org/obo/NCIT_C37172) (Hypolobated Neutrophil))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37169](http://purl.obolibrary.org/obo/NCIT_C37169) (Multilobated Neoplastic B-Lymphocyte))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C37165](http://purl.obolibrary.org/obo/NCIT_C37165) (Atypical Lymphocyte))) 47.86%


